Clinical Data Demonstrates Significantly Increased Cure Rates Using Resistance Guided Therapy for Treating the STI Superbug M. Genitalium

SYDNEY, Australia, Jun. 21 (Korea Bizwire) — SpeeDx Pty. Ltd. today announced clinical data contained in a new study published in the June 2018 issue of Clinical Infectious Diseases1 [ link] supports the use of Resistance Guided Therapy for more effective treatment of Mycoplasma genitalium infections. Using the SpeeDx ResistancePlus® MG test, the authors recorded [...]